Immune patterns of the tumor microenvironment in PD-L1+ EGFR+ HNSCC patients received anti-PD-1 and EGFR-based neoadjuvant therapy

Yuan Zhi(Central South University), Keqian Zhi(Qingdao University), Jianzhong Song(Xinjiang Medical University), Ling Gao(Nanjing Medical University), Jingjing Zheng(Qingdao University), Wenhao Ren(Qingdao University), Shaoming Li
Genes & Diseases
October 25, 2025
Cited by 1


Related Papers